Responding to Market Failures in Tuberculosis Control-Reference-Cited by-同舟云学术

Responding to Market Failures in Tuberculosis Control

Published:2001-08-10 Issue:5532 Volume:293 Page:1049-1051
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Gupta Rajesh¹²,Kim Jim Y.²,Espinal Marcos A.¹,Caudron Jean-Michel³,Pecoul Bernard⁴,Farmer Paul E.²,Raviglione Mario C.¹

Affiliation:

1. R. Gupta, M. A. Espinal, and M. C. Raviglione are with the Stop TB Department, Communicable Diseases, World Health Organization (WHO), 20 Avenue Appia, Geneva, Switzerland.

2. R. Gupta, J. Y. Kim, and P. E. Farmer are in the Program in Infectious Diseases and Social Change, Harvard Medical School, Boston, MA 02115, USA.

3. J.-M. Caudron is with Médecins Sans Frontières (MSF), Artsen Zonder Grenzen-Rue Dupréstraat, 94 1090 Brussels, Belgium.

4. B. Pecoul is with Access to Essential Medicines, MSF, Case Postale 6090, CH1211 Geneva 6, Switzerland.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference27 articles.

1. Tuberculosis Undefeated

2. Kim J. Y., et al., Dying for Growth (Common Courage Press, Cambridge, MA, 2000).

3. Farmer P., Infections and Inequalities (Common Courage Press, Cambridge, USA, 2000).

4. Harvard Medical School and Open Society Institute Global Impact of Drug-Resistant Tuberculosis (Program in Infectious Disease and Social Change Boston MA 1999).

5. Suarez P. G., et al., J. Infect. Dis., in press.

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tuberculosis commodities supply chain performance in the WHO African region: A scoping review;PLOS Global Public Health;2024-05-16

2. Policy gaps in addressing market failures and intervention misalignments in tuberculosis control: prospects for improvement in China, India, and Indonesia;The Lancet Regional Health - Western Pacific;2024-05

3. Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis;The Lancet Diabetes & Endocrinology;2021-12

4. Process and operations strategies to enable global access to antibody therapies;Biotechnology Progress;2021-03-16

5. Tuberculosis-a World Health Organization Perspective;Tuberculosis and Nontuberculous Mycobacterial Infections;2017-04-27